The 60 references in paper S. Sinkov V., I. Zabolotskikh B., S. Shaposhnikov A., С. Синьков В., И. Заболотских Б., С. Шапошников А. (2007) “Приобретенные коагулопатии: современные подходы к дифференциальной диагностике и интенсивной терапии с позиций доказательной медицины // Acquired Coagulopathies: Current Approaches to Differential Diagnosis and Intensive Care in the Context of Evidence-Based Medicine” / spz:neicon:reanimatology:910

1
Health A.Science policy committee of the Amerikan college of chest physians; 2000.
(check this in PDF content)
2
Chakraverty R., Davidson S., Peggs K. et al. The incidence and cause of coagulopathies in an intensive care population. Br. J. Haematol. 1996; 93: 460—463.
(check this in PDF content)
3
Синьков С. В., Аверьянова Л. Е. Частота и динамика развития ДВС! синдрома в абдоминальной хирургии. Вестн. интенс. терапии 2005; 5: 52—59.
(check this in PDF content)
4
Kitchens C. S. Consultative hemostasis and thrombosis. W.B.: Saunders Company; 2004.
(check this in PDF content)
5
Баркаган З. С., Момот А. П. Диагностика и контролируемая тера! пия нарушений гемостаза. М.: Ньюдиамед; 2001.
(check this in PDF content)
6
Момот А. П.Патология гемостаза: принципы и алгоритмы клини! ко!лабораторной диагностики. СПб.: Формат; 2006.
(check this in PDF content)
7
Ta y l o r F . B . , To n C . H . , H o o t s W . K . e t a l .Scientific and standardization committee communications: towards a definition. Clinical and laborato! ry criteria, and a scoring system for disseminated intravasciilar coagula! tion. Scientific subcommittee on disseminated intravascular coagulation (DIG) of the international society on thrombosis and haemostasis; 2001.
(check this in PDF content)
8
Matsuda T.Clinical aspects of DIC! disseminated intravascular coagu! lation. Pol. J. Pharmacol. 1996; 48 (1): 73—75.
(check this in PDF content)
9
Заболотских И. Б., Синьков С. В., Мануйлов А. М.Протокол диагно! стики и лечения синдрома диссеминированного внутрисосудисто! го свертывания. Вестн. интенс. терапии 2004; 5: 201—204.
(check this in PDF content)
10
Crowther M. A., Ginsberg J. S., Hirsh J.Practical aspects of anticoagulant therapy. In: George J. N. et al (еds). Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott Williams & Wi l k e n s . 2 0 0 1 : 1 4 9 7 — 1 5 1 6 .
(check this in PDF content)
11
Ragni M. V. Liver Disease, Organ transplantation, and hemostasis. In: Kitchens C. S. (ed). Consultative hemostasis and thrombosis. W.B.: Saunders Company; 2004. 481—492.
(check this in PDF content)
12
Deloughery T. G.Hemorrhagic and thrombotic disorders in the inten! sive care setting. In: Kitchens C. S. (ed). Consultative hemostasis and thrombosis. W. B.: Saunders Company; 2004. 493—514.
(check this in PDF content)
13
Angiolillo A., Abu!Ghosh A. M., Cairo M. S.General aspects of thrombo! cytopenia, platelet transfusions, and thrombopoietic growth factors. In: Kitchens C. S. (ed). Consultative hemostasis and thrombosis. W.B.: Saunders Company; 2004. 103—116.
(check this in PDF content)
14
Goebel R. A. Thrombocytopenia. Emerg. Med. Clin. North. Am. 1993; 11: 445—464.
(check this in PDF content)
15
Lilleyman J. S.Management of childhood idiopathic thrombocytopenic purpura. Br. J. Haematol. 1999; 105: 871—875.
(check this in PDF content)
16
Rebulla P., Finazzi G., Marangoni F. et al.The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N. Engl. J. Med. 1997; 337: 1870—1875.
(check this in PDF content)
17
Bellucci S., Charpak Y., Chastang C., Tobelem G. Low doses v conven! tional doses of corticoids in immune thrombocytopenic purpura (ITP): Results of a randomized clinical trial in 160 children, 223 adults. Blood 1988; 71: 1165—1169.
(check this in PDF content)
18
George J. N., Woolf S. H., Raskob G. E. et al.Idiopathic thrombocy! topenic purpura: A practice guideline developed by explicit methods for the American society of hematology. Blood 1996; 88: 3—40.
(check this in PDF content)
19
Law C., Marcaccio M., Tarn P. et al. High!dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N. Engl. J. Med. 1997; 336: 1494—1498.
(check this in PDF content)
20
Pizzuto J., Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the cooperative Latin American group on hemostasis and thrombosis. Blood 1984; 64: 1179—1183.
(check this in PDF content)
21
Burrows R. F., Kelton J. G.Pregnancy in patients with idiopathic throm! bocytopenic purpura: Assessing the risks for the infant at delivery. Obstet. Gynecol. Surv. 1993; 48 (12): 781—788.
(check this in PDF content)
22
Guyatt G., Schunemann H., Cook D. et al. Grades of recommendation for antithrombotic agents. Chest 2001; 119: 3—7.
(check this in PDF content)
23
Hirsh J., Warkentin T. E., Shaughnessy S. G. et al.Heparin and low!mol! ecular!weight heparin: mechanisms of action, pharmacokinet!ics. dos! ing, monitoring, efficacy, and safety. Chest 2001; 119: 64—94.
(check this in PDF content)
24
Marcus A .J. In: Kaplan B. S., Trompeter R. S., Moake J. L. (eds). Hemolytic uremic syndrome and thrombotic thrombocytopenic purpu! ra. N.Y.: Marcel Dekker; 1992. 19—27.
(check this in PDF content)
25
Moake J. L.Thrombotic thrombocytopenic purpura. In: Kitchens C.S. (ed.) Consultative hemostasis and thrombosis. W.B.: Saunders Company; 2004. 343—354.
(check this in PDF content)
26
Zeigler Z. R., Shadduck R. K., Gryn J. F. et al.Cryoprecipitate poor plas! ma does not improve early response in primary adult thrombotic throm! bocytopenic purpura (TTP). J. Clin. Apheresis 2001; 16: 19—22.
(check this in PDF content)
27
Sarode R., McFarland J. G., Flomenberg N. et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombot! ic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant. 1995; 16: 271—275.
(check this in PDF content)
28
Minakami H., Sato I.HELLP syndrome. JAMA 1999; 281: 703—704.
(check this in PDF content)
29
Miller R. D. Transfusion therapy. In: Miller R.D. (ed.) Miller's Anesthesia; 2005. 1799—1830.
(check this in PDF content)
30
Guidelines for the use of platelet transfusions. Brit. J. Haematology 2003; 122:10—23.
(check this in PDF content)
31
Рандомизированные клинические испытания коллоидных плазмо! замещающих растворов на основе модифицированной желатины и гидроксиэтилкрахмала. Отечественный и зарубежный опыт их применения. Сб. ст. СПб.; 2002.
(check this in PDF content)
32
Воробьев А. И.Руководство по гематологии. М.:Ньюдиамед; 2005.
(check this in PDF content)
33
Bolan C. D.Transfusion medicine and pharmacologic aspects of hemo! stasis. In: Kitchens C.S. (ed). Consultative hemostasis and thrombosis. W. B . : S a u n d e r s C o m p a n y ; 2 0 0 4 . 3 9 5 — 4 1 6 .
(check this in PDF content)
34
Schafer A. Bleeding and thrombosis in myeloproliferative disorders. Blood 1984; 64: 1—12.
(check this in PDF content)
35
Becker R. C., Berkowitz S. D.Hemostatic aspects of cardiovascular med! icine In: Kitchens C. S. (ed). Consultative hemostasis and thrombosis. W. B . : S a u n d e r s C o m p a n y ; 2 0 0 4 . 2 7 9 — 3 1 0 .
(check this in PDF content)
36
Carr J. A., Silverman N.The heparin!protamine interaction. A review. J. Cardiovasc. Surg. (Torino) 1999; 40: 659—666.
(check this in PDF content)
37
Crowther M. A., Ginsberg J. S., Hirsh J. Practical aspects of anticoagulant therapy. In: Colman R. W. et al. (eds). Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott Williams & Wi l k e n s ; 2 0 0 1 . 1 4 9 7 — 1 5 1 6 .
(check this in PDF content)
38
Butler A. C., Tait R. C.Management of oral anticoagulant!induced intracranial haemorrhage. Blood Rev. 1998; 12: 35—44.
(check this in PDF content)
39
Crowther M. A., Julian J., McCarty D. et al. Treatment of warfarin!asso! ciated coagulopathy with oral vitamin K: a randomised con trolled trial. Lancet 2000; 356: 1551—1553.
(check this in PDF content)
40
Hylek E. M., Chang Y. C., Skates S. J. et al.Prospective study of the out! comes of ambulatory patients with excessive warfarin anticoagulation. Arch. Intern. Med. 2000; 160: 1612—1617.
(check this in PDF content)
41
Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant. Brit. J. Haematology 2004; 126:11—28.
(check this in PDF content)
42
Barrons R. W., Jahr J. S.A Review of post!cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin. Am. J. Ther. 1996; 3 (12): 821—838.
(check this in PDF content)
43
Kyriss T., Wurst H., Friedel G. et al.Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo!controlled, randomized phase IV study. Semin Thromb. Hemost. 1997; 23: 365—370.
(check this in PDF content)
44
Samama C. M., Langeron O., Rosencher N. et al. Aprotinin versus place! bo in major orthopedic surgery: a randomized, double!blinded, dose! ranging study. Anesth. Analg. 2002; 95 (2): 287—293.
(check this in PDF content)
45
Frenette L., Cox J., McArdle P. et al.Conjugated estrogen reduces trans! fusion and coagulation factor requirements in orthotopic liver trans! plantation. Anesth. Analg. 1998; 86: 1183—1186.
(check this in PDF content)
46
Kang Y. G., Lewis J. H., Novalgund A. et al.Epsilon aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987; 66: 766—773.
(check this in PDF content)
47
Boylan J. F., Klinck J. R., Sandier A. N. et al.Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996; 85:1043—1048.
(check this in PDF content)
48
Porte R. J., Molenaar B., Groenland T. H. N., et al.Aprotonin and trans! fusion requirements in orthotopic liver transplantation: a multicenter randomised double!blind study. Lancet 2000; 355: 1303—1309.
(check this in PDF content)
49
Bronner M. H., Pate M. B., Cunningham J. T., Marsh W. H.Estrogen!proges! terone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial. Ann. Intern. Med. 1986; 105: 371—374.
(check this in PDF content)
50
Mannucci P. M.Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997; 90: 2515—2521.
(check this in PDF content)
51
Moia M., Mannucci P. M., Vizzotto L. et al.Improvement in the haemo! static defect of uraemia after treatment with recombinant human ery! thropoietin. Lancet 1987; 2 (8570): 1227—1229.
(check this in PDF content)
52
Tr i u l z i D . J . , B l u m b e r g N . Va r i a b i l i t y i n r e s p o n s e t o c r y o p r e c i p i t a t e t r e a t ! ment for hemostatic defects in uremia. Yale J. Biol. Med. 1990; 63: 1—7.
(check this in PDF content)
53
Dice R. D.Intraoperative disseninated intravascular coagulopathy. Crit. Care Nursing Clin. N. Amer. 2000; 12 (2): 175—179.
(check this in PDF content)
54
Hebert P. C., Wells G., Marshall J. et al. Transfusion requirements in crit! ical care: A pilot study. JAMA 1999; 273: 1439—1444.
(check this in PDF content)
55
Baglin T., Barrowcliffe T. W., Cohen A., Greaves M. Guidelines on the use and monitoring of heparin. Brit. Society Haematol. 2006; 133: 19—34.
(check this in PDF content)
56
Hardaway R. M., Williams C. H., Vasquez Y.Disseminated intravascular coagulation in sepsis. Semin Thromb. Hemost. 2001; 27(6): 577—583.
(check this in PDF content)
57
Jonge E., Eevi M., Stoutenbeek C. P., van Deventer S. J. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 1998; 55 (6): 767—77.
(check this in PDF content)
58
Kitchens C. S. Disseminated Intravascular Coagulation. In: Kitchens C.S. (ed). Consultative hemostasis and thrombosis. W.B.: Saunders Company; 2004. 165—178.
(check this in PDF content)
59
Levi M. M., Vink R., de Jonge.Management of bleeding disorders by progemostatic therapy. Int. J. Hematol. 2002; 76 (Suppl 2): 139—144.
(check this in PDF content)
60
Hirasawa H., Baue A. E.Blood purificacion therapy to prevent or treat MOF. In: Baue A. E., Faist E., Fry D. E. (eds). Multiple organ failure. N.Y.: Springer!Verlag; 2000. 501—504. Поступила 15.08.07
(check this in PDF content)